Neurocrine Bioscience buy JPMorgan Chase & Co.
Start price
07.08.24
/
50%
€132.10
Target price
07.08.25
€165.67
Performance (%)
-0.11%
Price
09:30
€131.95
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ for Neurocrine Bioscience is nearly unchanged. This prediction currently runs until 07.08.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Neurocrine Bioscience | -0.11% |
iShares Core DAX® | -5.630% |
iShares Nasdaq 100 | -8.559% |
iShares Nikkei 225® | -9.576% |
iShares S&P 500 | -6.631% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at JPMorgan Chase & Co. from $173.00 to $181.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€135.00
10.07.24
10.07.24
€159.75
10.07.25
10.07.25
-2.26%
09:30
09:30
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€128.85
20.03.24
20.03.24
€145.64
20.03.25
20.03.25
2.41%
09:30
09:30
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€124.00
23.02.24
23.02.24
€136.69
23.02.25
23.02.25
6.41%
09:30
09:30
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.25
13.09.23
13.09.23
€124.83
13.09.24
13.09.24
23.03%
09:30
09:30